Abstract
Supplementary Figure from Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have